Acclimatization of microalgae Arthrospira platensis for treatment of heavy metals in Yamuna River

Bioaccumulation and biosorption in microalgae are effective approaches for the removal of heavy metals (HMs) from river water. The objective of this study was to investigate the potential for use of acclimatized microalgae in the removal of HMs from the Yamuna River water as an acclimatizing medium. An active culture of Arthrospira platensis (A. platensis) was acclimatized to HMs up to a concentration of 100 mg/L. It was gradually exposed to increasing concentrations of HMs in five subsequent batches with a step increase of 20 mg/L to acclimatize live cells in the simulated Yamuna River water. The presence of high levels of HMs in the Yamuna River water caused growth inhibition. An empirical growth inhibition model was developed, and it predicted high threshold concentrations of HMs (210.7–424.5 mg/L), producing a positive specific growth rate of A. platensis. A. platensis also showed high average removal efficiencies of HMs, including 74.0% for Cu, 77.0% for Cd, 50.5% for Ni, 76.0% for Cr, 76.5% for Pb, and 63.5% for Co, from HMs-enriched Yamuna River water. The findings demonstrated that the maximum specific removal amounts of Cu, Cd, Ni, Cr, Pb, and Co were 54.0, 58.0, 39.0, 62.8, 58.9, and 45.3 mg/g, respectively. The maximum yields of the value-added products chlorophyll and phycocyanin were 2.5 mg/g (in a batch of 40 mg/L for Cd) and 1 054 mg/g (in a batch of 20 mg/L for Cu), respectively. Therefore, acclimatized A. platensis was proven to be a potential microalga not only for sequestration of HMs but also for production of valuable pigments.     

ElectroBlocks: A blockchain‐based energy trading scheme for smart grid systems

Smart grid systems are widely used across the world for providing demand response management between users and service providers. In most of the energy distributions scenarios, the traditional grid systems use the centralized architecture, which results in large transmission losses and high overheads during power generation. Moreover, owing to the presence of intruders or attackers, there may be a mismatch between demand and supply between utility centers (suppliers) and end users. Thus, there is a need for an automated energy exchange to provide secure and reliable energy trading between users and suppliers. We found, from the existing literature, that blockchain can be an effective solution to handle the aforementioned issues. Motivated by these facts, we propose a blockchain‐based smart energy trading scheme, ElectroBlocks, which provides efficient mechanisms for secure energy exchanges between users and service providers. In ElectroBlocks, nodes in the network validate the transaction using two algorithms that are cost aware and store aware. The cost‐aware algorithm locates the nearest node that can supply the energy, whereas the store‐aware algorithm ensures that the energy requests go to the node with the lowest storage space. We evaluated the performance of the ElectroBlocks using performance metrics such as mining delay, network exchanges, and storage energy. The simulation results obtained demonstrate that ElectroBlocks maintains a secure trade‐off between users and service providers when using the proposed cost‐aware and store‐aware algorithms.     

Current Understanding of the Interplay between Phytohormones and Photosynthesis under Environmental Stress

Abiotic stress accounts for huge crop losses every year across the globe. In plants, the photosynthetic machinery gets severely damaged at various levels due to adverse environmental conditions. Moreover, the reactive oxygen species (ROS) generated as a result of stress further promote the photosynthetic damage by inhibiting the repair system of photosystem II. Earlier studies have suggested that phytohormones are not only required for plant growth and development, but they also play a pivotal role in regulating plants’ responses to different abiotic stress conditions. Although, phytohormones have been studied in great detail in the past, their influence on the photosynthetic machinery under abiotic stress has not been studied. One of the major factors that limits researchers fromelucidating the precise roles of phytohormones is the highly complex nature of hormonal crosstalk in plants. Another factor that needs to be elucidated is the method used for assessing photosynthetic damage in plants that are subjected to abiotic stress. Here, we review the current understanding on the role of phytohormones in the photosynthetic machinery under various abiotic stress conditions and discuss the potential areas for further research.     

Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities

Melanoma is the deadliest form of skin cancer and remains a diagnostic challenge in the dermatology clinic. Several non-invasive imaging techniques have been developed to identify melanoma. The signal source in each of these modalities is based on the alteration of physical characteristics of the tissue from healthy/benign to melanoma. However, as these characteristics are not always sufficiently specific, the current imaging techniques are not adequate for use in the clinical setting. A more robust way of melanoma diagnosis is to “stain” or selectively target the suspect tissue with a melanoma biomarker attached to a contrast enhancer of one imaging modality. Here, we categorize and review known melanoma diagnostic biomarkers with the goal of guiding skin imaging experts to design an appropriate diagnostic tool for differentiating between melanoma and benign lesions with a high specificity and sensitivity.     

Powering Implantable and Ingestible Electronics

Implantable and ingestible biomedical electronic devices can be useful tools for detecting physiological and pathophysiological signals, and providing treatments that cannot be done externally. However, one major challenge in the development of these devices is the limited lifetime of their power sources. The state-of-the-art of powering technologies for implantable and ingestible electronics is reviewed here. The structure and power requirements of implantable and ingestible biomedical electronics are described to guide the development of powering technologies. These powering technologies include novel batteries that can be used as both power sources and for energy storage, devices that can harvest energy from the human body, and devices that can receive and operate with energy transferred from exogenous sources. Furthermore, potential sources of mechanical, chemical, and electromagnetic energy present around common target locations of implantable and ingestible electronics are thoroughly analyzed; energy harvesting and transfer methods befitting each energy source are also discussed. Developing power sources that are safe, compact, and have high volumetric energy densities is essential for realizing long-term in-body biomedical electronics and for enabling a new era of personalized healthcare.     

Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells

Aberrant nuclear protein transport, often observed in cancer, causes mislocalization-dependent inactivation of critical cellular proteins. Earlier we showed that overexpression of exportin 1 is linked to higher grade and Gleason score in metastatic castration resistant prostate cancer (mCRPC). We also showed that a selective inhibitor of nuclear export (SINE) selinexor and second generation eltanexor (KPT-8602) could suppress mCRPC growth, reduce androgen receptor (AR), and re-sensitize to androgen deprivation therapy. Here we evaluated the combination of KPT-8602 with PARP inhibitors (PARPi) olaparib, veliparib and rucaparib in 22rv1 mCRPC cells. KPT-8602 synergized with PARPi (CI < 1) at pharmacologically relevant concentrations. KPT-8602-PARPi showed superior induction of apoptosis compared to single agent treatment and caused up-regulation of pro-apoptotic genes BAX, TP53 and CASPASE 9. Mechanistically, KPT-8602-PARPi suppressed AR, ARv7, PSA and AR targets FOXA1 and UBE2C. Western blot analysis revealed significant down-regulation of AR, ARv7, UBE2C, SAM68, FOXA1 and upregulation of cleaved PARP and cleaved CASPASE 3. KPT-8602 with or without olaparib was shown to reduce homologous recombination-regulated DNA damage response targets including BRCA1, BRCA2, CHEK1, EXO1, BLM, RAD51, LIG1, XRCC3 and RMI2. Taken together, this study revealed the therapeutic potential of a novel combination of KPT-8602 and PARP inhibitors for the treatment of mCRPC.